自发性细菌性腹膜炎预防与治疗进展

doi:10.3969/j.issn.1672-5069.2014.04.004

Abstract

Huang Lihua, Zhang Ying. Prevention and treatment of spontaneous bacterial peritonitis: what is new?[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(4): 348-352.

[1] Gines P,Angeli P,Lenz K,et al.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis. J Hepatol,2010,53（3）:397- 417.
[2] Burri E,Schulte F,Muser J,et al. Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count. World J Gastroenterol,2013,19（13）:2028-2036.
[3] Lippi G,Danese E,Cervellin G,et al. Laboratory diagnostics of spontaneous bacterial peritonitis. Clin Chim Acta,2014,20:164-170.
[4] Mostafa MS,El-Seidi EA,Kassem AM,et al. Detection of ascitic fluid infections in patients with liver cirrhosis and ascites. Arab J Gastroenterol,2011,12（1）:20-24.
[5] Cho Y,Park SY,Lee JH,et al. High-sensitivity C-reactive protein level is an independent predictor of poor prognosis in cirrhotic patients with spontaneous bacterial peritonitis. J Clin Gastroenterol,2014,48（5）:444-449.
[6] Shalimar1 H,Acharya SK. Difficult to treat spontaneous bacterial peritonitis. Trop Gastroenterol,2013,34（1）:7-13.
[7] Alexopoulou A,Papadopoulos N,Eliopoulos DG,et al. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int,2013,33（7）:975-981.
[8] 卜昕,张文瑾,范振平,等.肝硬化并发自发性细菌性腹膜炎患者腹水感染161 例的细菌种类及耐药分析.中华临床医师杂志, 2012,6（13）:3734-3737.
[9] 涂清鲜,袁萍萍.病毒性重症肝炎并发自发性腹膜炎病原菌分析.吉林医学,2011,32（3）:556.
[10] Bhat G,Vandana KE,Bhatia S,et al. Spontaneous ascitic fluid infection in liver cirrhosis:bacteriological profile and response to antibiotic therapy.Indian J Gastroenterol,2013,32（5）:297-301.
[11] 姚光弼. 临床肝脏病学. 上海：上海科学技术出版社,2011,181-186.
[12] Acevedo JL,Prado V,Fernández J,et al. Changing options for prevention and treatment of infections in cirrhosis. Curr Treat Options Gastroenterol,2014,12（2）:256-267.
[13] Badawy AA,Zaher T,Sharaf SM,et al. Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis. World J Gastroenterol,2013,19（8）:1271-1277.
[14] Yakar T,Güclü M,Serin E,et a1.A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. Dig Dis Sci,2010,55（4）：1149-1154.
[15] Guevara M,Terra C,Nazar A,et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.A randomized,controlled study. J Hepatol,2012,57（4）:759-765.
[16] Narula N,Tsoi K,Marshall JK. Should albumin be used in all patients with spontaneousbacterial peritonitis Can J Gastroenterol,2011,25（7）:373-376.
[17] Garcia-Martinez R,Caraceni P,Bernardi M,et al. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology,2013,58（5）:1836-1846.
[18] Rena NM,Wibawa ID.Albumin infusion in liver cirrhotic patients. Acta Med Indones,2010,42（3）：162-168.
[19] Deshpande A,Pasupuleti V,Thota P,et al. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients:a meta-analysis.J Gastroenterol Hepatol,2013,28（2）:235-242.
[20] Kwon JH,Koh SJ,Kim W,et al. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis. J Gastroenterol Hepatol,2014,29（4）:775-781.
[21] 郑三菊,王崇慧,占国清.微生态制剂治疗肝硬化自发性细菌性腹膜炎疗效观察. 中国微生态学杂志,2014,26（1）:62-65.
[22] Cesaro C,Tiso A,Del Prete A,et al. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis,2011,43（6）:431-438.
[23] Pereg D,Kotliroff A,Gadoth N,et al.Probiotics for patients with compensated liver cirrhosis:a double-blind placebo-controlled study. Nutrition,2011,27（2）:177-181.
[24] Saab S,Hernandez JC,Chi AC,et al.Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis. Am J Gastroenterol,2009,104（4）:993-1001.
[25] Lontos S,Shelton E,Angus PW,et al. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients. J Dig Dis,2014,15（5）:260-267.
[26] Lee YY,Tee HP,Mahadeva S. Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. World J Gastroenterol,2014,20（7）:1790-1796.

Prevention and treatment of spontaneous bacterial peritonitis: what is new?

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[6]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[7]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[10]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[11]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[12]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[13]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[14]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[15]	Han Meiling, Chen Ping. Antiviral therapy in patients with liver cirrhosis and thrombocytopenia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 466-469.